chr1-11949854-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000302.4(PLOD1):​c.250G>A​(p.Ala84Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0136 in 1,614,080 control chromosomes in the GnomAD database, including 293 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 101 hom., cov: 32)
Exomes 𝑓: 0.012 ( 192 hom. )

Consequence

PLOD1
NM_000302.4 missense

Scores

2
3
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 8.06
Variant links:
Genes affected
PLOD1 (HGNC:9081): (procollagen-lysine,2-oxoglutarate 5-dioxygenase 1) Lysyl hydroxylase is a membrane-bound homodimeric protein localized to the cisternae of the endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VI have deficiencies in lysyl hydroxylase activity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033874512).
BP6
Variant 1-11949854-G-A is Benign according to our data. Variant chr1-11949854-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 263938.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-11949854-G-A is described in Lovd as [Benign]. Variant chr1-11949854-G-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0621 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLOD1NM_000302.4 linkc.250G>A p.Ala84Thr missense_variant Exon 3 of 19 ENST00000196061.5 NP_000293.2 Q02809-1
PLOD1NM_001316320.2 linkc.391G>A p.Ala131Thr missense_variant Exon 4 of 20 NP_001303249.1 Q02809-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLOD1ENST00000196061.5 linkc.250G>A p.Ala84Thr missense_variant Exon 3 of 19 1 NM_000302.4 ENSP00000196061.4 Q02809-1

Frequencies

GnomAD3 genomes
AF:
0.0253
AC:
3843
AN:
152184
Hom.:
98
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0638
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0157
Gnomad ASJ
AF:
0.00576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0174
Gnomad FIN
AF:
0.00565
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0109
Gnomad OTH
AF:
0.0220
GnomAD2 exomes
AF:
0.0137
AC:
3437
AN:
251456
AF XY:
0.0129
show subpopulations
Gnomad AFR exome
AF:
0.0660
Gnomad AMR exome
AF:
0.0102
Gnomad ASJ exome
AF:
0.00804
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.00531
Gnomad NFE exome
AF:
0.0103
Gnomad OTH exome
AF:
0.0134
GnomAD4 exome
AF:
0.0124
AC:
18081
AN:
1461778
Hom.:
192
Cov.:
31
AF XY:
0.0123
AC XY:
8942
AN XY:
727200
show subpopulations
Gnomad4 AFR exome
AF:
0.0650
AC:
2175
AN:
33468
Gnomad4 AMR exome
AF:
0.0104
AC:
467
AN:
44724
Gnomad4 ASJ exome
AF:
0.00788
AC:
206
AN:
26136
Gnomad4 EAS exome
AF:
0.000126
AC:
5
AN:
39700
Gnomad4 SAS exome
AF:
0.0171
AC:
1478
AN:
86256
Gnomad4 FIN exome
AF:
0.00610
AC:
326
AN:
53404
Gnomad4 NFE exome
AF:
0.0111
AC:
12311
AN:
1111930
Gnomad4 Remaining exome
AF:
0.0163
AC:
984
AN:
60392
Heterozygous variant carriers
0
995
1990
2986
3981
4976
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
522
1044
1566
2088
2610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0254
AC:
3866
AN:
152302
Hom.:
101
Cov.:
32
AF XY:
0.0247
AC XY:
1837
AN XY:
74490
show subpopulations
Gnomad4 AFR
AF:
0.0642
AC:
0.064163
AN:
0.064163
Gnomad4 AMR
AF:
0.0156
AC:
0.015623
AN:
0.015623
Gnomad4 ASJ
AF:
0.00576
AC:
0.00576037
AN:
0.00576037
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.0178
AC:
0.0178275
AN:
0.0178275
Gnomad4 FIN
AF:
0.00565
AC:
0.00564972
AN:
0.00564972
Gnomad4 NFE
AF:
0.0109
AC:
0.0109373
AN:
0.0109373
Gnomad4 OTH
AF:
0.0218
AC:
0.0217803
AN:
0.0217803
Heterozygous variant carriers
0
187
374
560
747
934
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0146
Hom.:
94
Bravo
AF:
0.0276
TwinsUK
AF:
0.0108
AC:
40
ALSPAC
AF:
0.0122
AC:
47
ESP6500AA
AF:
0.0617
AC:
272
ESP6500EA
AF:
0.0114
AC:
98
ExAC
AF:
0.0149
AC:
1803
Asia WGS
AF:
0.0110
AC:
39
AN:
3478
EpiCase
AF:
0.0122
EpiControl
AF:
0.0118

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 21, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 08, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ehlers-Danlos syndrome, kyphoscoliotic type 1 Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 28, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
May 28, 2015
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Ehlers-Danlos syndrome Benign:1
Jul 09, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.33
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.059
.;T;T
Eigen
Uncertain
0.44
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Benign
0.86
D;T;D
MetaRNN
Benign
0.0034
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.0
.;.;M
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-2.1
N;N;N
REVEL
Benign
0.082
Sift
Benign
0.086
T;D;D
Sift4G
Benign
0.087
T;T;T
Polyphen
0.63
.;.;P
Vest4
0.20
MPC
0.28
ClinPred
0.052
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.16
gMVP
0.59
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34878020; hg19: chr1-12009911; API